Patent ID: 8574586

Claim:
A method of treating tumors in a subject comprising administering to the subject one or more peptides of any one of (a) to (e): (a) a nonapeptide consisting of the amino acid sequence of SEQ ID NO: 30, (b) a peptide with cytotoxic T cell inducibility, wherein zero, one or two amino acids are substituted to the amino acid sequence of SEQ ID NO: 30, and the peptide binds to an HLA-A0201 restricted T cell receptor with high affinity and induces a high CTL response, (c) the peptide of (b), wherein the second amino acid from the N terminus is leucine or isoleucine, (d) the peptide of (c), wherein the peptide consists of the amino acid sequence of SEQ ID NO: 54, and (e) the peptide of (b) or (c), wherein the C-terminal amino acid is leucine.